Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-18-006658
Filing Date
2018-05-11
Accepted
2018-05-11 12:11:23
Documents
67
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cerc10-q20180331.htm 10-Q 1062002
2 EXHIBIT 2.1 q12018cercexhibit21.htm EX-2.1 400621
3 EXHIBIT 10.2 q12018cercexhibit102.htm EX-10.2 218344
4 EXHIBIT 31.1 q12018cercex-311.htm EX-31.1 12630
5 EXHIBIT 31.2 q12018cercex-312.htm EX-31.2 12626
6 EXHIBIT 32.1 q12018cercex-321.htm EX-32.1 11588
  Complete submission text file 0001628280-18-006658.txt   7534235

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cerc-20180331.xml EX-101.INS 1394949
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cerc-20180331.xsd EX-101.SCH 57507
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cerc-20180331_cal.xml EX-101.CAL 77508
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cerc-20180331_def.xml EX-101.DEF 329110
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cerc-20180331_lab.xml EX-101.LAB 760888
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cerc-20180331_pre.xml EX-101.PRE 462558
Mailing Address 400 E. PRATT ST. SUITE 606 BALTIMORE MD 21202
Business Address 400 E. PRATT ST. SUITE 606 BALTIMORE MD 21202 410-522-8707
Cerecor Inc. (Filer) CIK: 0001534120 (see all company filings)

EIN.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37590 | Film No.: 18825860
SIC: 2834 Pharmaceutical Preparations